10
Participants
Start Date
April 3, 2023
Primary Completion Date
December 23, 2023
Study Completion Date
June 8, 2024
Baricitinib 4 MG
The patients received Baricitinib for 48 weeks. The method is to take Baricitinib 4mg every day for a period of 48 weeks. All the patients will be followed up prospectively for 48 weeks.
Department of Rheumatology and Immunology, Peking University People's Hospital, Beijing
Liu Tian
OTHER